The new hepatitis C virus bottleneck: Can delaying therapy be justified?
Tracey G. Simon, Raymond T. Chung – 8 June 2015
Lipocalin‐2 (NGAL/LCN2), a “help‐me” signal in organ inflammation
Anastasia Asimakopoulou, Erawan Borkham‐Kamphorst, Frank Tacke, Ralf Weiskirchen – 5 June 2015
MiR‐199a‐5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer
Weijie Guo, Zhaoping Qiu, Zhichao Wang, Qifeng Wang, Ning Tan, Taoyang Chen, Zhiao Chen, Shenglin Huang, Jianren Gu, Jinjun Li, Ming Yao, Yingjun Zhao, Xianghuo He – 5 June 2015 – Cancer cells possess a unique metabolic phenotype that allows them to preferentially utilize glucose through aerobic glycolysis. This phenomenon is referred to as the “Warburg effect.” Accumulating evidence suggests that microRNAs (miRNAs), a class of small noncoding regulatory RNAs, interact with oncogenes/tumor suppressors and induce such metabolic reprograming in cancer cells.
Reply
Mingjiang Xu, Dechun Feng, Bin Gao – 5 June 2015
Pure laparoscopic management of early biliary leakage after liver transplantation: Abdominal lavage and T‐Tube placement
Ailton Sepulveda, Raffaele Brustia, Fabiano Perdigao, Olivier Soubrane, Olivier Scatton – 4 June 2015
Pretransplant management of basilar artery aneurysm and moyamoya disease in a child with Alagille syndrome
Marco Pavanello, Mariasavina Severino, Lorenzo D'Antiga, Lucio Castellan, Angela Calvi, Michele Colledan, Carlo Gandolfo – 4 June 2015
Hepatocellular carcinoma surveillance in hepatitis B virus–infected individuals: Who and how?
Ka‐Kit Li, Palak J. Trivedi, Sophie Von Heimendahl, Tony Bruns, Steve T. Ward, Ye Oo, David Mutimer – 4 June 2015
Thrombolytic protocol minimizes ischemic‐type biliary complications in liver transplantation from donation after circulatory death donors
Laura C. Burlage, Shanice A. Karangwa, Ton Lisman, Paulo N. A. Martins, Robert J. Porte – 4 June 2015
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
James H. Tabibian, Steven P. O'Hara, Christy E. Trussoni, Pamela S. Tietz, Patrick L. Splinter, Taofic Mounajjed, Lee R. Hagey, Nicholas F. LaRusso – 4 June 2015 – Primary sclerosing cholangitis (PSC) is a chronic, idiopathic, fibroinflammatory cholangiopathy. The role of the microbiota in PSC etiopathogenesis may be fundamentally important, yet remains obscure. We tested the hypothesis that germ‐free (GF) mutltidrug resistance 2 knockout (mdr2−/−) mice develop a distinct PSC phenotype, compared to conventionally housed (CV) mdr2−/− mice.